scholarly journals Antibacterial effects of Musa sp. ethanolic leaf extracts against methicillin-resistant and susceptible Staphylococcus aureus

2020 ◽  
Author(s):  
Lalita Ambigai Sivasamugham ◽  
Virusha Nimalan ◽  
Geetha Subramaniam
Keyword(s):  
Staphylococcus Aureus ◽  
Antibacterial Effects ◽  
Leaf Extracts ◽  
Methicillin Resistant ◽  
Musa Sp

scholarly journals In VitroActivities of Daptomycin-, Vancomycin-, and Teicoplanin-Loaded Polymethylmethacrylate against Methicillin-Susceptible, Methicillin-Resistant, and Vancomycin-Intermediate Strains of Staphylococcus aureus

2011 ◽  
Vol 55 (12) ◽  
pp. 5480-5484 ◽  
Author(s):  
Yuhan Chang ◽  
Wen-Chien Chen ◽  
Pang-Hsin Hsieh ◽  
Dave W. Chen ◽  
Mel S. Lee ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
High Performance ◽  
Low Dose ◽  
Antibacterial Activities ◽  
High Dose ◽  
Bone Cements ◽  
Antibacterial Effects ◽  
Methicillin Resistant ◽  
Content Type

ABSTRACTThe objective of this study was to evaluate the antibacterial effects of polymethylmethacrylate (PMMA) bone cements loaded with daptomycin, vancomycin, and teicoplanin against methicillin-susceptibleStaphylococcus aureus(MSSA), methicillin-resistantStaphylococcus aureus(MRSA), and vancomycin-intermediateStaphylococcus aureus(VISA) strains. Standardized cement specimens made from 40 g PMMA loaded with 1 g (low-dose), 4 g (middle-dose) or 8 g (high-dose) antibiotics were tested for elution characteristics and antibacterial activities. The patterns of release of antibiotics from the cement specimens were evaluated usingin vitrobroth elution assay with high-performance liquid chromatography. The activities of broth elution fluid against differentStaphylococcus aureusstrains (MSSA, MRSA, and VISA) were then determined. The antibacterial activities of all the tested antibiotics were maintained after being mixed with PMMA. The cements loaded with higher dosages of antibiotics showed longer elution periods. Regardless of the antibiotic loading dose, the teicoplanin-loaded cements showed better elution efficacy and provided longer inhibitory periods against MSSA, MRSA, and VISA than cements loaded with the same dose of vancomycin or daptomycin. Regarding the choice of antibiotics for cement loading in the treatment ofStaphylococcus aureusinfection, teicoplanin was superior in terms of antibacterial effects.

scholarly journals IN VITRO SCREENING FOR ANTIMICROBIAL POTENTIAL OF ETHANOLIC LEAF EXTRACTS OF SOME BEGONIA SPECIES AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) STRAIN

2020 ◽  
pp. 30-38
Author(s):  
Halyna Tkachenko ◽  
Natalia Kurhaluk ◽  
Lyudmyla Buyun ◽  
Vladimir Tomin
Keyword(s):  
Staphylococcus Aureus ◽  
Antimicrobial Activity ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Inhibition Zone ◽  
Leaf Extracts ◽  
Test Protocol ◽  
Methicillin Resistant ◽  
Highly Active ◽  
Ethanolic Extracts

The antimicrobial activities of ethanolic extracts obtained from the leaves of Begonia solimutata L.B. Sm. & Wassh., Begonia goegoensis N.E.Br., Begonia foliosa Kunth, Begonia × erythrophylla Hérincq, Begonia thiemei C.DC., Begonia peltata Otto & Dietr., Begonia heracleifolia Cham. & Schltdl., Begonia dregei Otto & Dietr., and Begonia mexicana G. Karst. ex Fotsch were assessed against methicillin-resistant Staphylococcus aureus (MRSA) strain. The leaves were brought into the laboratory for antimicrobial studies. Freshly crushed leaves were washed, weighed, and homogenized in 96% ethanol (in proportion 1:19) at room temperature. The extracts were then filtered and investigated for their antimicrobial activity. The testing of the antibacterial activity of the plant extracts was carried out in vitro by the Kirby-Bauer disc diffusion susceptibility test protocol. The most effective plants among species screened against S. aureus NCTC 12493 growth were B. peltata, B. thiemei, B. foliosa, Begonia × erythrophylla, and B. solimutata being highly active with the ethanolic extracts (diameters of inhibition zone ranged from 12.5 to 21 mm). The ethanolic extracts from nine Begonia plant species were evaluated for their antimicrobial activity against methicillin-resistant S. aureus (MRSA) strain. Extracts from all test Begonia plants caused a remarkable reduction in bacterial growth, measured as an inhibition zone diameters. The diameter of the inhibition zone for B. solimutata was (16.4±1.1) mm, for B. goegoensis – (14.2±1.0) mm, for B. foliosa – (14.9±1.2) mm, for Begonia × erythrophylla – (16.9±0.9) mm, for B. thiemei – (16.8±1.3) mm, for B. peltata – (18.1±0.9) mm, for B. heracleifolia – (15.3±0.9) mm, for B. dregei – (14.7±1.1) mm, and for B. mexicana – (13.8±0.9) mm/ The highly active antimicrobial effects of extracts obtained from B. peltata and B. thiemei noted against S. aureus NCTC 12493 growth is worthy of highlighting. Our studies indicated that Begonia plants are worthy of further investigation as a potential phytotherapeutic agent for treating infections caused by S. aureus., as well as for the development of innovative feed and preventative products in animal husbandry.

scholarly journals Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study

2017 ◽  
Vol 242 (7) ◽  
pp. 731-743 ◽  
Author(s):  
Chiu-Fai Kuok ◽  
Sai-On Hoi ◽  
Chi-Fai Hoi ◽  
Chi-Hong Chan ◽  
Io-Hong Fong ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Inhibitory Concentration ◽  
Synergistic Effects ◽  
Medicinal Herbs ◽  
Resistant Bacteria ◽  
Antibacterial Effects ◽  
In Vitro Susceptibility ◽  
Methicillin Resistant

Antibiotic resistance has become a serious global concern, and the discovery of antimicrobial herbal constituents may provide valuable solutions to overcome the problem. In this study, the effects of therapies combining antibiotics and four medicinal herbs on methicillin-resistant Staphylococcus aureus (MRSA) were investigated. Specifically, the synergistic effects of Magnolia officinalis, Verbena officinalis, Momordica charantia, and Daphne genkwa in combination with oxacillin or gentamicin against methicillin-resistant (ATCC43300) and methicillin-susceptible (ATCC25923) S. aureus were examined. In vitro susceptibility and synergistic testing were performed to measure the minimum inhibitory concentration and fractional inhibitory concentration (FIC) index of the antibiotics and medicinal herbs against MRSA and methicillin-susceptible S. aureus. To identify the active constituents in producing these synergistic effects, in silico molecular docking was used to investigate the binding affinities of 139 constituents of the four herbs to the two common MRSA inhibitory targets, penicillin binding proteins 2a (PBP2a) and 4 (PBP4). The physicochemical and absorption, distribution, metabolism, and excretion properties and drug safety profiles of these compounds were also analyzed. D. genkwa extract potentiated the antibacterial effects of oxacillin against MRSA, as indicated by an FIC index value of 0.375. M. officinalis and V. officinalis produced partial synergistic effects when combined with oxacillin, whereas M. charantia was found to have no beneficial effects in inhibiting MRSA. Overall, tiliroside, pinoresinol, magnatriol B, and momorcharaside B were predicted to be PBP2a or PBP4 inhibitors with good drug-like properties. This study identifies compounds that deserve further investigation with the aim of developing therapeutic agents to modulate the effect of antibiotics on MRSA. Impact statement Antibiotic resistant is a well-known threat to global health and methicillin-resistant Staphylococcus aureus is one of the most significant ones. These resistant bacteria kill thousands of people every year and therefore a new effective antimicrobial treatment is necessary. This study identified the herbs and their associated bioactive ingredients that can potential the effects of current antibiotics. These herbs have long history of human usage in China and have well-defined monograph in the Chinese Pharmacopeia. These indicate their relatively high clinical safety and may have a quicker drug development process than that of a new novel antibiotic. Based on the results of this study, the authors will perform further in vitro and animal studies, aiming to accumulate significant data for the application of clinical trial.

Sign in / Sign up

Export Citation Format

Share Document